Status:
Awaiting development
Technology type:
Medicine
Decision:
Selected
Prioritisation programme:
Medicines evaluation
Rationale:

Criteria within the 2024 Voluntary Scheme for Pricing, Access and Growth (VPAG)  met as a significant licence extension.

Process:
STA Standard
ID number:
12405

Email enquiries

If you have any queries please email Topic.Selection@nice.org.uk

Timeline

Key events during the development of the guidance:

Date Update
27 April 2026 Awaiting development. Status change linked to topic prioritisation decision being set to Selected
16 April 2026 Prioritisation board meeting

For further information on our processes and methods, please see our CHTE processes and methods manual